Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Liang Ho

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2014
Antroquinonol blocks Ras and Rho signaling via the inhibition of protein isoprenyltransferase activity in cancer cellsChing-Liang Ho, Jui-Ling Wang, Cheng-Chung Lee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 12, 2010
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patientsNai-Shun Yao, Yi-Ying Wu, Anthony J Janckila, et al.
Plos One|September 19, 2019
Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysisWei-Nung Liu, Chao-Feng Chang, Chi-Hsiang Chung, et al.
Molecular and Clinical Oncology|March 21, 2014
Malignant bowel obstruction: A retrospective clinical analysisJia-Hong Chen, Tzu-Chuan Huang, Ping-Ying Chang, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 27, 2014
Gefitinib as first-line treatment for patients with epidermal growth factor receptor-mutated advanced lung adenocarcinoma: a single institution experience in TaiwanShiue-Wei Lai, Ching-Liang Ho, Ming-Shen Dai, et al.
Annals of Hematology|December 17, 2009
The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of TaiwanWei-Liang Chen, Wen-Chiuan Tsai, Tsu-Yi Chao, et al.
Scientific Reports|July 18, 2020
Gene expression profiling identifies the role of Zac1 in cervical cancer metastasisHui-Chen Su, Sheng-Cheng Wu, Li-Chen Yen, et al.
Plos One|May 25, 2019
The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based studyPing-Ying Chang, Chi-Hsiang Chung, Wei-Chou Chang, et al.
Leukemia & Lymphoma|November 11, 2014
Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab eraChieh-Sheng Lu, Jia-Hong Chen, Tzu-Chuan Huang, et al.
Molecular Cancer Research : MCR|July 23, 2008
Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa CellsPei-Yao Liu, James Yi-Hsin Chan, Hsiu-Chen Lin, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2014
Antroquinonol blocks Ras and Rho signaling via the inhibition of protein isoprenyltransferase activity in cancer cellsChing-Liang Ho, Jui-Ling Wang, Cheng-Chung Lee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 12, 2010
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patientsNai-Shun Yao, Yi-Ying Wu, Anthony J Janckila, et al.
Plos One|September 19, 2019
Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysisWei-Nung Liu, Chao-Feng Chang, Chi-Hsiang Chung, et al.
Molecular and Clinical Oncology|March 21, 2014
Malignant bowel obstruction: A retrospective clinical analysisJia-Hong Chen, Tzu-Chuan Huang, Ping-Ying Chang, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 27, 2014
Gefitinib as first-line treatment for patients with epidermal growth factor receptor-mutated advanced lung adenocarcinoma: a single institution experience in TaiwanShiue-Wei Lai, Ching-Liang Ho, Ming-Shen Dai, et al.
Annals of Hematology|December 17, 2009
The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of TaiwanWei-Liang Chen, Wen-Chiuan Tsai, Tsu-Yi Chao, et al.
Scientific Reports|July 18, 2020
Gene expression profiling identifies the role of Zac1 in cervical cancer metastasisHui-Chen Su, Sheng-Cheng Wu, Li-Chen Yen, et al.
Plos One|May 25, 2019
The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based studyPing-Ying Chang, Chi-Hsiang Chung, Wei-Chou Chang, et al.
Leukemia & Lymphoma|November 11, 2014
Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab eraChieh-Sheng Lu, Jia-Hong Chen, Tzu-Chuan Huang, et al.
Molecular Cancer Research : MCR|July 23, 2008
Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa CellsPei-Yao Liu, James Yi-Hsin Chan, Hsiu-Chen Lin, et al.
Pageof 16